University of Chicago Medicine
Department of Pathology
MC0004, TW010
5841 S. Maryland Avenue
Chicago, IL 60637
ComACC Accredited: 2012
| Program Director | Associate Director | Program Admin |
|---|---|---|
| KT Jerry Yeo, PhD, DABCC, FADLM | Clarence W. Chan, MD, PhD, DABCC | Angela Terry |
| Clinical Professor of Pathology | Assistant Professor of Pathology and Assistant Director of Clinical Chemistry | Program Coordinator |
| jyeo@bsd.uchicago.edu | Clarence.Chan@bsd.uchicago.edu | Angela.Terry@uchicagomedicine.org |
| (773) 702-1318 | (773) 702-1318 | (773) 702-1318 |
About the Program
The University of Chicago Department of Pathology offers a two-year postdoctoral fellowship in Clinical Chemistry starting July of every year. Clinical chemistry employs chemical, genomics, proteomics, and metabolomics applications in the assessment of health and disease. These laboratory data are used for diagnosis, prognosis and monitoring of disease, and guiding therapy in clinical medicine. This training will prepare the successful candidate for a career in clinical chemistry and laboratory medicine. Fellows are expected to take the American Board of Clinical Chemistry (ABCC) examination by the completion of the program.
Essential Functions of the Fellow
- Participate and manage clinical research projects in Clinical Chemistry, Clinical Mass Spectrometry & Clinical Pharmacogenomics that includes research, development, and validation of emerging biomarkers in clinical laboratory medicine, especially in the areas of pharmacogenomics, mass spectrometry and cardiology. Perform method validations and assist in implementation of new clinical chemistry tests. Provide consultations of clinical chemistry testing under the supervision of the laboratory director. Collaborate with clinical researchers to develop and provide appropriate clinical testing required for translational research projects as directed by the laboratory director.
- Participate in the education of students, pathology residents in clinical chemistry and pharmacogenomics. Be current with publications in clinical chemistry and laboratory medicine. Prepare and present cases and findings at several departmental and multidisciplinary conferences.
- Present research findings at national meetings and publish work in appropriate journals.
Program Requirements
To be considered for the program, prospective fellows must have:
- An earned doctoral degree (PhD) in biochemistry, analytical chemistry, pharmacology, molecular biology, or a related biomedical science or a MD/DO degree with preferably 1-2 years of research experience in a research laboratory.
- Applicants are limited to those within the first five years of their first doctoral degree per institutional policy.
- Satisfactorily completed a minimum of 30 semester hours (U.S. equivalent) in undergraduate and/or graduate level chemistry or biochemistry courses prior to admission into the program to meet certification eligibility requirements by the American Board of Clinical Chemistry.
To Apply
Applications may be sent in starting June for position starting the following year in July. We may conduct informal discussion by phone or at ADLM conference prior to arranging for formal interviews starting September 1st.
The application packet must include:
- Cover letter with personal statement of interest (2-page maximum)
- Curriculum vitae
- Undergraduate and PhD transcripts
- Three letters of recommendation
Submit via email to program coordinator (Angela Terry) with a copy sent to program director (Dr. Jerry Yeo). Incomplete applications will not be considered.
Training Level
| Postdoctoral Training Level |
|---|
| Number of positions available per year: 1 per year |
| Duration of program: 2 years |
| Approximate annual salary or stipend: PGY Scale |
| Source of funding: Department Funded |
| Current number of trainees: 2 |
| Number of past graduates: 7 |
Faculty
| Kathleen G. Beavis, MD | Cost-Effective Diagnosis of Infectious Diseases, Clostridium Difficile, HIV-1, Tuberulosis, Global Health |
| Timothy Carll, MD | Transfusion Medicine, Point-of-Care Testing |
| Clarence Chan, MD, PhD, DABCC | Clinical Chemistry, Clinical Proteomics, Clinical Informatics, Mass Spectrometry, Clinical Pharmacogenomics |
| Soma Das, PhD, FACMG | Molecular Diagnosis of Human Genetic Diseases |
| Carrie A. Fitzpatrick, PhD, FACMG | Autism, Cancer Cytogenetics, Constitutional Cytogenetics, Cytogenomics, Prenatal Genetic Diagnosis |
| Sandeep Gurbuxani, MBBS, PhD | Hematopathology, Mechanism of Chemotherapy Resistance, Hematologic Malignancies |
| Angela Lager, PhD, FACMG | Chromosomal Microarray, Cytogenetics, FISH, Molecular Genetics |
| Melissa Pessin, MD, PhD | Point-of-Care, Clinical Informatics, Predictive Value of Tests, Test Utilization |
| Vishnu Samara, PhD | Clinical Chemistry, Laboratory Automation, Mass Spectrometry, Quality Assurance |
| Jeremy P. Segal, MD, PhD | Next-Generation Sequencing, Bioinformatics Tools for Cancer Genomics Discovery and Clinical Testing |
| Vera Tesic, MD | Clinical Microbiology and Immunology |
| Geoffrey Wool, MD, PhD | Acquired Coagulation Factor Inhibitors, Platelet Immunology |
| KT Jerry Yeo, PhD, DABCC | Clinical Chemistry, Clinical Pharmacogenomics, Cardiac Biomarkers, Angiogenic Biomarkers, Clinical Mass Spectrometry |

